AEterna Zentaris Inc. (AEZS)

[joelk]

Gary, I than you very much for taking the time to explain the approval process, you are very knowledgeable on the company drugs, here are some follow-up questions:

1. you say phase four is a post approval trial which FDA can require but is not necessary for approval, I believe you also said both perifosine & AEXZ 130 could end phase 3 before the end of this year, & get an expedited approval, thenfile an NDA & get final approval by the first half of next year. In your opinion would you say the odds are good that this will happen & will the stock price show a huge advance long before this happening?

2. What is the next piece of bullish news we could expect from the company that will advance the stock price.